Product Information
PTC299 is a monoclonal antibody that binds to the CD20 protein on the surface of lymphocytes. This binding prevents CD20 from transmitting signals, leading to apoptotic cell death. PTC299 has been shown to be effective in treating chronic lymphocytic leukemia and eye disorders. The most common side effects are headache, nausea, vomiting, diarrhea, dizziness, and fatigue.
Chemical properties
Technical inquiry about: 3D-GAC56536 PTC299
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.